Table I.
Pathophysiologic Actions of Aldosterone That Promote Hypertension and Increase Cardiovascular Risk
Sodium retention/volume expansion |
Reduction in vascular compliance |
Promotion of endothelial dysfunction |
Upregulation of angiotensin II receptors |
Potentiation of the pressor responses of angiotensin II |
Increases in sodium influx in vascular smooth muscle cells |
Fibrosis in the heart, kidneys, and vasculature |
Activation of plasminogen activator inhibitor 1 |
Stimulation of transforming‐growth factor β1 |
Stimulation of reactive oxygen species |
Hypertrophy of vascular smooth muscle cells and myocardial cells |
Increase in blood lipid levels |
Hypokalemia resulting in increased potential for cardiac arrhythmias, glucose intolerance, insulin resistance |
Hypomagnesemia resulting in increased potential for cardiac arrhythmias |